Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Peloton Interactive Inc (PTON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Peloton Interactive Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Peloton Interactive Inc trades at $5.04 (market cap $2.30B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 3.9× Peloton Interactive Inc's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Peloton Interactive Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Peloton Interactive Inc for 37 Days on average.
| KYMR | PTON | |
|---|---|---|
Market Cap | $8.87B | $2.30B |
Volume | 779,107 | 9,511,173 |
Sector | Health | Consumer Cyclical |
52-Week High | $127.31 | $7.86 |
52-Week Low | $55.80 | $3.71 |
Typical Hold Time | 0 Days | 37 Days |
Enterprise Value | $8.26B | $2.80B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Peloton (PTON) trades at $5.06, down 1.56% today, showing mixed technical signals with a bullish overall rating but bearish moving averages. The company achieved its first profitable year in 2026 with $63M net income, though Q3 2026 earnings are pending. Revenue declined from $3.6B in 2022 to $2.4B in 2026, but profitability improved significantly with net margin turning positive. Recent product launches include new treadmills and AI features, signaling ongoing turnaround efforts.
PTON presents a speculative opportunity with analyst consensus price target of $8.00 (58% upside) and 50% buy ratings. Key risks include declining subscriber counts, high debt levels, and competitive pressures. The stock's valuation appears reasonable with P/S of 0.93, but negative shareholder equity and volatile cash flow history warrant caution. Near-term catalyst will be Q3 2026 earnings results versus expectations of $0.1098 EPS.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Peloton Interactive Inc
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →
